35^th World Congress for Neurorehabilitation August 07-08, 2023 Amsterdam, Netherlands

The 35th World Congress for Neurorehabilitation will be held in Amsterdam, the Netherlands, from August 07–08, 2023. The topic of this will be "Determination of various approaches in the field of Neurorehabilitation," and it will include a number of crucial sessions that are held in an intense format. This conference will include information on advancements in the field of neurorehabilitation as well as cutting-edge treatment methods that have been developed by researchers to cure a variety of disorders in a less demanding manner. This conference is the ideal venue for anyone looking to learn more about this trend in cutting-edge neurorehabilitation work.

The most recent advancements in each area of neurorehabilitation can be the focus of Neurorehabilitation 2023. Additionally, neurorehabilitation provides a notable window of opportunity for people all around the world to engage, plan, and comprehend fresh developments in neuroscience. Workshops, poster presentations, video presentations, symposiums, and spectacular keynote speeches by renowned speakers who go above and beyond the call of duty in the field of neurorehabilitation are all part of this conference. As we support the Poster Award Competition and Young Understudies at the gathering venue, this 35th World Congress for Neurorehabilitation meeting energizes the vibrant gathering of young research forums, upcoming specialists, and growing researchers.

• Alzheimer’s and Parkinson’s Diseases
• Amyotrophic lateral sclerosis (ALS)
• Brain Mapping & Biomarkers
• Brain Tumours and Brain Cancer
• Clinical Neurology
• Clinical Neurophysiology
• Cognitive Neuroscience
• Diabetic neuropathy
• Epilepsy
• Geriatric Neurology
• Neurodegeneration and Aging Disorders
• Neurogenetic and Neurometabolic Disorders
• Neurogenomics
• Neurological Diseases
• Neuropathology
• Neurorehabilitation
• Neurosurgery
• Paediatric Neurology
• Psychiatry
• Stroke and Neurovascular Diseases

Neurorehabilitation Market Statistics 2030:

The global neurorehabilitation market size was valued at $ 1,097.69 million in 2020 and is projected to reach $ 2,451.25 million by 2030 registering a CAGR of 8.3% from 2021 to 2030. Neurorehabilitation is a complex medical process, which aims to aid recovery from a nervous system injury, and to minimize and/or compensate for any functional alterations resulting from it. Neurorehabilitation devices facilitate to reduce symptoms and improve neurological related function. This device is most commonly used for physiotherapy and to improve patient quality life.

Growth in prevalence of neurological disorders such as brain stroke, Parkinson's disease, multiple sclerosis, cerebral palsy, traumatic brain injury, spinal cord injury, and rise in awareness about neurorehabilitation devices among population are some factors which drive growth of the neurorehabilitation market. In addition, increase in funding for R&D, and rise in product approvals of neurorehabilitation devices by regulatory authorities further boost growth of the neurorehabilitation market. However, high cost of neurorehabilitation devices and lack of skilled professionals are some key factors that hamper growth of the market. On the contrary, increase in demand for tele rehabilitation creates an opportunity for manufacturers to tap and capitalize on the market.

Impact Of Covid-19 On Neurorehabilitation Market (Pre And Post Analysis)

The outbreak of COVID-19 has disrupted workflows in the health care sector around the world. The disease has forced a number of industries to shut their doors temporarily, including several sub-domains of health care. In several countries, neurorehabilitation units have had to reduce their bed numbers to allow doctors and nurses to work in intensive care units or in dedicated wards to isolate and take care of patients with COVID-19 infection. Home and outpatient rehabilitation services are restricted to selected cases, for protection of both patients and caregivers. Similarly, in-patient neurorehabilitation has been limited to patients with severe post-acute disabilities, and those suffering from chronic degenerative diseases such as movement disorders or multiple sclerosis are postponed for long time. 

Despite small reduction in the number of strokes and other acquired brain injuries attended at emergency departments and acute care hospitals, explained by fear of contracting the virus at hospital, the prevalence of these neurological diseases has not drastically changed over time. However, incidences of these neurological disorders and the demand for neurorehabilitation therapy has increased. Therefore, specialized neurorehabilitation units need to adapt their facilities and resources to enable better management both for patients with SARS-CoV-2 infection and usual patients. These tools, which include telemedicine for consultations and follow-up (teleconsultations), subsequent outpatient rehabilitation therapy, and use of specific software (tele rehabilitation), also enable adequate communication with families of hospitalized patients while observing safety measures and avoiding unnecessary visits.

Neurorehabilitation Market Segmentation  

The global neurorehabilitation market is segmented on the basis of type, application, end user, and region. By type, it is segmented into neuro-robotic devices, non-invasive stimulators, and brain-computer interfaces. By application, it is segmented into brain stroke, Parkinson's disease, multiple sclerosis, spinal cord injury, traumatic brain injury, cerebral palsy, and others. By end user, it is categorized into rehabilitation centers, hospitals, and clinics. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Segment Review

By type, the neurorehabilitation market is segmented into neuro-robotic devices, non-invasive stimulators, and brain-computer interfaces. The non-invasive stimulators segment dominated the global market in 2020 and is expected to remain dominant throughout the forecast period, owing to factors such as increasing technological advancements in non-invasive stimulators and rising demand of the non-invasive methods for neurorehabilitation.